Price T Rowe Associates Inc Axsome Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$883 Billion
Q2 2025

A detailed history of Price T Rowe Associates Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 612,743 shares of AXSM stock, worth $71.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

612,743

Previous 31,977 1816.2%

Holding current value

$71.5 Million

Previous $3.73 Million 1614.91%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$95.65 - $116.49 $55.6 Million - $67.7 Million	580,766 Added 1816.2%	612,743 $64 Million
Q1 2025 May 14, 2025	BUY	$80.05 - $137.75 $59,957 - $103,174	749 Added 2.4%	31,977 $3.73 Million
Q4 2024 Feb 14, 2025	BUY	$83.08 - $100.49 $279,647 - $338,249	3,366 Added 12.08%	31,228 $2.64 Million
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $54,224 - $65,842	687 Added 2.53%	27,862 $2.5 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $124,933 - $153,030	1,901 Added 7.52%	27,175 $2.19 Million
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $8.42 Million - $11.8 Million	-121,283 Reduced 82.75%	25,274 $2.02 Million
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $7.12 Million - $10.4 Million	123,949 Added 548.25%	146,557 $11.7 Million
Q3 2023 Nov 14, 2023	BUY	$69.25 - $82.21 $147,641 - $175,271	2,132 Added 10.41%	22,608 $1.58 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $246,899 - $381,909	4,227 Added 26.01%	20,476 $1.47 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $103,350 - $132,750	1,770 Added 12.22%	16,249 $1 Million
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $15,177 - $30,293	380 Added 2.7%	14,479 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$36.06 - $69.85 $19,039 - $36,880	-528 Reduced 3.61%	14,099 $630,000
Q2 2022 Aug 15, 2022	BUY	$21.74 - $46.75 $5,326 - $11,453	245 Added 1.7%	14,627 $560,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $96,411 - $168,374	4,068 Added 39.44%	14,382 $595,000
Q4 2021 Feb 14, 2022	SELL	$30.7 - $43.36 $300,737 - $424,754	-9,796 Reduced 48.71%	10,314 $390,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $14.5 Million - $49.7 Million	-728,137 Reduced 97.31%	20,110 $663,000
Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $6.12 Million - $8.89 Million	120,909 Added 19.27%	748,247 $50.5 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $23 Million - $33.5 Million	-411,917 Reduced 39.64%	627,338 $35.5 Million
Q4 2020 Feb 16, 2021	BUY	$66.31 - $86.52 $68.9 Million - $89.9 Million	1,039,255 New	1,039,255 $84.7 Million

Others Institutions Holding AXSM

# of Institutions

403

Shares Held

37.3M

Call Options Held

507K

Put Options Held

540K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Axsome Therapeutics, Inc. Transaction History